FOR THE LATEST DEVELOPING NEWS Click Here
Enrollment Locations for Open Label Extension (OLE)
Brazil has approved critically ill COVID Phase 3 to begin
Leronlimab COVID-19 Brazil Trial enrolled the first patient
Leronlimab’s Mechanism of Action in COVID-19 Published
Leronlimab/Receptor Occupancy - Published
Leronlimab Published in Journal of Translational Autoimmunity
Dr. Seethamraju - Special isirv-AVG Virtual Conference
Leronlimab Potential in HIV PrEP
CytoDyn reveals results for cancer and NASH patients
Long-Hauler Trial Endpoints
Oncology Presentation
CCR5 closes the 1 temporal window for memory linking
CD15 Patients’ Testimonies
CytoDyn to Hold Webcast and Live Q/A on October 26
View the latest financials
